Abstract 3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase) controls the rate of cholesterol biosynthesis and is itself modulated through feedback suppression by internalized low density lipoprotein (LDL) cholesterol. We measured HMG CoA reductase protein concentration and microsomal enzyme activity in freshly isolated mononuclear leukocytes from normal individuals and patients with heterozygous or homozygous familial hypercholesterolemia (FH). Reductase protein concentration was similar in normal and heterozygous subjects, but was over twofold elevated in patients with homozygous FH. Reductase protein concentration was inversely related to LDL receptor status. Total activity and catalytic efficiency of reductase, however, were decreased in heterozygous and homozygous FH patients. The decrease in catalytic efficiency was not due to enzyme phosphorylation or thiol-disulfide formation. Reduction of plasma cholesterol concentration over 2 h by plasmapheresis increased reductase activity, the degree of which was directly proportional to the LDL-receptor status of the subjects.
Introduction
Under normal circumstances most human tissues are thought to derive most of their cholesterol from circulating lipoproteins, rather than from intracellular biosynthesis (1) . In healthy humans increased cellular demand for cholesterol stimulates the synthesis of cell surface receptors that bind and internalize predominantly low density lipoprotein (LDL) (2). LipoproDr. Harwood's present address is Atherosclerosis Section, Dept. of Metabolic Diseases, Pfizer Central Research, Pfizer Inc., Eastern Point Rd., Groton, CT 06340. Address correspondence to Dr. Stacpoole at the Division of Endocrinology and Metabolism, University ofFlorida, College of Medicine, Gainesville, FL 32610.
Received for publication 8 January 1987 and in revised form 27 May 1987. tein-derived cholesterol is not only used for diverse cellular functions but also inhibits the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase),' the endoplasmic reticulum enzyme that catalyzes the rate-determining step in cholesterol formation (3) . Thus, circulating cholesterol levels and endogenous cholesterol production are, in large part, coordinately controlled by receptor-mediated uptake of LDL (4, 5) .
In familial hypercholesterolemia (FH), however, the regulatory mechanisms ensuring cholesterol homeostasis are perturbed. In this dominantly transmitted condition, plasma cholesterol levels are increased and lead to premature atherosclerosis (6) . The etiology of the disease is considered to be an inherited abnormality in the uptake and metabolism of lipoprotein cholesterol. Patients heterozygous for FH are thought to possess only about half the normal number of functioning LDL receptors, while homozygous individuals exhibit little or no receptor activity (6) . Studies with culture fibroblasts suggest that, despite their reduced receptor status, cells from patients with heterozygous FH internalize sufficient lipoprotein cholesterol to maintain HMG CoA reductase in its normally suppressed state (7) . In contrast, it is presumed that the defect in receptor activity in homozygous subjects is so severe that feedback regulation of cholesterol biosynthesis by LDL is virtually absent and HMG CoA reductase activity is abnormally high (6, 7) .
We recently described sensitive and specific techniques for determining HMG CoA reductase activity (8) and protein concentration (9) in microsomal fractions from freshly isolated human mononuclear leukocytes. Studies in healthy human subjects (10) indicate that mononuclear leukocyte HMG CoA reductase activity responds to various nutritional and pharmacologic perturbations in a manner similar to that of the enzyme isolated from animal intestine or liver (1 1) . In the present investigation we measured the activity and protein content of HMG CoA reductase in mononuclear cells obtained from healthy adults and patients with heterozygous or homozygous FH. We found that enzyme protein concentration was elevated in cells from individuals with homozygous FH whereas both enzyme activity and catalytic efficiency were markedly decreased in cells derived from either heterozygous or homozygous patients. In addition, rapid reduction of plasma cholesterol levels by plasmapheresis induced a prompt increase in HMG CoA reductase activity that was proportional to the LDL-receptor status of the subject. pmol/min per mg) measured in the heterozygous group was in the subject receiving cholestyramine, a drug known to increase reductase activity in animal leukocytes (20) and other tissues (21) . Since enzyme protein levels were normal in mononuclear leukocytes from heterozygous individuals (Table II) , the diminished HMG CoA reductase activity observed in these subjects reflects a 70% decrease in the catalytic efficiency (i.e., specific activity) of the enzyme molecule (Table II ). An even greater reduction in enzyme catalytic efficiency (80% below normal) was noted in homozygous subjects (Table Il) (22) , and by reversible thioldisulfide formation, in which the reduced enzyme is active (23) . The method for isolating leukocyte microsomes (15) fully activates HMG CoA reductase with respect to phosphorylation and thiol-disulfide reduction. No further increase in enzyme activity was found when leukocyte microsomes were incubated in the presence of phosphoprotein phosphatase or 20 mM additional dithiothreitol (Table III) . Furthermore, the reduced enzyme activity in leukocytes from patients with FH persisted even after treatment with phosphatase or dithiothreitol.
Effects ofplasmapheresis. Fig. 3 summarizes the results of plasmapheresis in six subjects. Serum total and LDL-cholesterol concentrations decreased -60% below basal in all individuals immediately after a 2-h plasma exchange. Similar changes were noted for serum HDL cholesterol and triglycer- magnitude of change in HMG CoA reductase activity in response to a rapid reduction in circulating lipoprotein cholesterol concentration was related to the LDL-receptor status of the subjects.
To determine the effect of plasmapheresis on mononuclear cell subpopulations, leukopheresis was conducted in a patient with heterozygous FH during a 4-liter plasma exchange. Leukopheresis was performed during the first and last liters of plasma exchange and the cells were separated into monocyteand lymphocyte-enriched populations. As shown in Fig. IV Regardless of the precise mechanism for suppression of HMG CoA reductase activity in FH, it is noteworthy that subjects with heterozygous FH and those with receptor-defective homozygous disease are able to show increased enzyme activity after rapid lowering of circulating cholesterol by plasmapheresis, whereas patients with LDL-receptor-negative homozygous FH exhibit little or no change in HMG CoA reductase activity after plasmapheresis. These results, and our previous studies (10) , indicate that the effect of plasma exchange on mononuclear leukocyte HMG CoA reductase activity is due principally, if not entirely, to stimulation of the monocyte enzyme. The stimulation of HMG CoA reductase activity and, presumably, cholesterol biosynthesis, by plasmapheresis may provide insight into the rapid restoration of circulating cholesterol levels after this procedure in patients with FH (26-28). By removing large amounts of serum lipoprotein, plasmapheresis may derepress HMG CoA reductase in white cells and other tissues and, consequently, stimulate whole body cholesterolgenesis. Such an effect has been described in rats undergoing plasma exchange (29) . Thus, both increased de novo cholesterol formation and decreased receptor-mediated uptake of lipoprotein cholesterol may mediate the restoration of circulating lipid levels after plasmapheresis in FH patients.
The apparent suppression of basal mononuclear HMG CoA reductase activity in FH may seem at variance with the results obtained in numerous experiments with cultured human cells (6, 7) . Indeed, it is postulated that most normal cells derive the majority oftheir cholesterol from receptor-mediated endocytosis of lipoprotein cholesterol, rather than from receptor-independent endocytosis or from intracellular synthesis (1) . Moreover, this model suggests that lipoprotein cholesterol, or a metabolite of cholesterol, acts to maintain HMG CoA reductase in a chronically suppressed state, in part by inhibiting transcription of the HMG CoA reductase gene (1) . By this mechanism, therefore, changes in cellular demand for cholesterol would be met principally by increasing or decreasing availability of LDL receptors, rather than by altering HMG CoA reductase activity or protein (2). Studies with fibroblasts maintained in culture for up to 72 h indicate that, in heterozygous FH, only approximately half the normal number of LDL receptors are present (7) . This number is still sufficient, however, to provide enough cholesterol to meet the metabolic requirements of the cell and to maintain HMG CoA reductase in a repressed state. In contrast, cultured fibroblasts from patients with LDL-receptor-negative homozygous disease are forced to derive the bulk of their cholesterol from endogenous biosynthesis (1). Consequently, HMG CoA reductase activity in these cells is abnormally high (3, 6, 7) . In this regard, it has been reported that the activity of HMG CoA reductase is severalfold greater than normal in cultured fibroblasts obtained from patients with homozygous FH, while enzyme activity in cells from heterozygous patients is normal (3) .
Several aspects of these classic experiments, however, require careful interpretation. First, in these studies, HMG CoA reductase protein concentration was not measured directly but was inferred from changes in the activity of the fully dephosphorylated enzyme (3) . Thus the reported differences in enzyme activity in FH versus normal cells could have been due either to a change in HMG CoA reductase protein concentration or catalytic efficiency, independent of the effects of phosphorylation. Indeed, our study is the first, to our knowledge, to quantitate immunpreactive HMG CoA reductase protein levels in cells from FH subjects and to relate enzyme protein concentration to microsomal enzyme activity. Second, experiments in which reductase activity in cultured FH fibroblasts was reported to be increased were conducted after incubation of these cells for at least 24 h in media containing a small percentage (usually 10%) of fetal calf serum (3, 7) . While the concentration of lipoprotein cholesterol in such media would be sufficient to meet cellular cholesterol needs in normal fibroblasts, it is appreciably less than the extracellular cholesterol concentration to which homozygous FH cells are chronically exposed in vivo. Thus, since fibroblasts from FH homozygotes cannot efficiently internalize lipoprotein cholesterol, longterm incubation of cells in dilute serum would maximally derepress HMG CoA reductase synthesis and stimulate intracellular cholesterolgenesis. Consistent with this prediction is the finding that, in normal cultured cells transferred from lipoprotein-replete to lipoprotein-deficient media, HMG CoA reductase synthesis is derepressed to a level of enzyme activity similar to that observed in FH homozygous cells cultured in dilute serum or in lipoprotein-deficient medium (7). Finally, many investigators have reported that the high levels of HMG CoA reductase activity are not altered in cultured cells from homozygous FH patients by short-term exposure to concentrations of LDL cholesterol that markedly inhibit the enzyme in normal cells (3, 6, 7, 30, 31) . In virtually all these experiments, however, medium concentrations of lipoprotein cholesterol did not exceed 200 mg/dl. This concentration is substantially below the level of circulating LDL cholesterol present in the vast majority of untreated patients with heterozygous or homozygous disease (1). Thus, an LDL-receptor-independent process for cellular uptake of circulating cholesterol, operating at chronically high ambient levels of cholesterol, would have been missed by the experimental conditions used with cultured cells. Moreover, our results are consistent with studies indicating that intestinal (32) and hepatic (33) HMG CoA reductase activities measured in freshly isolated tissues, as well as total body cholesterol synthesis (34) (35) (36) , are usually normal or decreased in adults with FH.
If it is assumed that the suppression of HMG CoA reductase activity in mononuclear leukocytes and other cells of FH patients is due in some way to elevated serum cholesterol concentrations, then there are several mechanisms other than receptor-mediated uptake of LDL that could account for our findings. For example, receptors for cholesterol-enriched remnant particles of VLDL catabolism are present on monocytes and certain other cells from both normal individuals and patients with FH (37) (38) (39) (40) . Remnant lipoproteins may be increased in FH and are capable of mediating inhibition of HMG CoA reductase (37) . In addition, a low affinity, nonreceptor-mediated (scavenger) pathway exists in monocytes and other cells for uptake of lipoprotein cholesterol (8) 
